At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SEIFEM 2015: Fungemia in Hematologic Malignancies
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne·observational·Posted May 22, 2015·Updated Oct 20, 2016
In Brief
An observational study for Acute Leukemia and 3 related conditions. Completed, enrolled 300 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the risk factors for fungemia in a population of patients diagnosed with hematologic malignancies and eligible for chemotherapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Leukemia, Chronic Leukemia, Multiple Myeloma, Lymphoma
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedMay 2015
Primary CompletionDec 2015
Study CompletionJan 2016
TodayJul 2026
First PostedMay 22, 2015
Enrollment StartJan 1, 2011
Primary CompletionDec 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 11.1 years ago